Skip to main content
Erschienen in: Virchows Archiv 2/2017

01.08.2017 | Erratum

Erratum to: Managing the genomic revolution in cancer diagnostics

verfasst von: Doreen Nguyen, Christopher D. Gocke

Erschienen in: Virchows Archiv | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Erratum to: Virchows Arch
Table 2
Clinical Laboratory
Test Name
Panel Details
Methodology/ Platform
Tumor/Normal Sequencing
Turnaround Time (TAT)
CPT® Code(s)
URL Source/Reference
Brigham and Women’s Hospital, Center for Advanced Molecular Diagnostics Boston, MA
OncoPanel
275 genes (full coding regions) plus selected intronic regions of 30 genes
Hybrid-capture, Illumina (HiSeq™)
Plans to implement in the future
3 weeks
Not specified
[12]
City of Hope Clinical Molecular Diagnostic Laboratory Duarte, CA
OncoMutations Panel
49 genes (mutation hotspots)
Amplicon-based, Ion AmpliSeq™ technology
No
14 days
81,445, 88,381, G0452
OncoComplete (OncoMutations PLUS OncoFusions)
49 genes (mutation hotspots), fusion transcripts for 53 genes
Amplicon-based, Ion AmpliSeq™ technology
No
14 days
81,445, 81,479, 88,381, G0452(×2)
Columbia University Laboratory for Personalized Genomic Medicine New York, NY
TruSeq Targeted Cancer Panel
48 genes
Amplicon-based, Illumina (TruSeq®)
No
30 days
81,445, 88,381
Combined Cancer Panel (CCCP)
467 genes (393-exons only; 74-whole genes)
Amplicon-based, Illumina (TruSeq®)
No
30 days
81,455, 88,381
Duke University Health System Durham, NC
Solid Tumor Hotspot NGS Panel
50 genes (mutation hotspots)
Amplicon-based, Ion AmpliSeq™ technology
No
14 days
81,445
Emory University Molecular Diagnostics Lab Atlanta, GA
Cancer Mutation Panel 26 (CMP26)
26 genes (whole-exon coverage)
Amplicon-based, Illumina (TruSight® Tumor 26)
No
7–10 days
81,445, G0452
Jefferson Cancer Genomics Laboratory Philadelphia, PA
Ion Ampliseq™ Cancer Panel
50 genes
Amplicon-based, Ion AmpliSeq™ technology
No
14 days
Not specified
Johns Hopkins Molecular Diagnostics Laboratory Baltimore, MD
50 Gene Panel
50 genes (mutation hotpots)
Amplicon-based, Ion AmpliSeq™ technology
No
10–14 days
81,445
Massachusetts General Hospital, Center for Integrated Diagnostics Boston, MA
NGS SNaPshot
39 genes (mutation hotspots)
Primer single-base extension, SNaPShot™ methodology
No
3 weeks
Not specified
Memorial Sloan Kettering Cancer Center New York, NY
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT™)
410 genes, 17 rearrangements
Hybrid-capture, Illumina (HiSeq™)
Yes
Not specified
Not specified
[34]
New York Presbyterian Hospital/Weill Cornell Molecular Pathology Laboratory New York, NY
Cancer Gene Mutation Panel-50 (CGMP-50)
50 genes (mutation hotspots)
Amplicon-based, Ion AmpliSeq™ technology
No
7–10 days
81,445
Oregon Health & Science University, Knight Diagnostic Laboratories Portland, OR
GeneTrails® Comprehensive Solid Tumor Panel
124 genes
Amplicon-based, Illumina (NextSeq™)
No
14 days
81,455
GeneTrails® Solid Tumor Fusion Gene Panel
fusions in 20 target genes, gene expression for 8 genes
Next generation RNA sequencing, confirmation by FISH
No
14–17 days
81,455
Stanford Molecular Pathology Laboratory Palo Alto, CA
Solid Tumor Actionable Mutation Panel (STAMP)
130 genes (either in part or fully)
Hybrid-capture, Illumina (MiSeq™)
No
28 days
81,455
Cancer Somatic Mutation Panel, Non-Blood
48 genes (targeted regions and hotspot mutations)
Hybrid-capture, Illumina (MiSeq™); primer single-base extension, SNaPShot™ methodology for 2 genes
No
28 days
81,445
The Ohio State University Wexner Medical Center Molecular Pathology Laboratory Columbus, OH
Lung Cancer Mutation Panel (PULMOL)
26 genes (commonly mutated regions)
Amplicon-based, Ion AmpliSeq™ technology
No
Not specified
81,445, G0452
Colon Cancer Mutation Panel (COLMOL)
26 genes (commonly mutated regions)
Amplicon-based, Ion AmpliSeq™ technology
No
Not specified
81,445, G0452
UC San Diego Health, Center for Advanced Laboratory Medicine, Clinical Genomics Laboratory San Diego, CA
Comprehensive NGS Solid Tumor Mutation Panel
397 genes (all exons), transcripts for 28 genes
NGS
Yes
16 days
Not specified
UC San Francisco Clinical Cancer Genomics Laboratory San Francisco, CA
UCSF500 Cancer Gene Panel
~500 genes (including select introns), fusions involving 42 genes
Hybrid-capture, Illumina (HiSeq™)
Yes
3–4 weeks
Not specified
University of Chicago Molecular Pathology Laboratory Chicago, IL
OncoPlus Universal Cancer Mutation Analysis Panel
147 clinically reported genes, fusions in ALK, RET, ROS1
Hybrid-capture, Illumina (HiSeq™)
No
14–20 days
81,455
University of Nebraska Medical Center Regional Pathology Services Omaha, NE
50 Gene Panel
50 genes (mutation hotpots)
Amplicon-based, Ion AmpliSeq™ technology
No
10–14 days
Not specified
University of Pennsylvania, Center for Personalized Diagnostics Philadelphia, PA
Comprehensive Solid Tumor Panel
153 genes (mutation hotspots)
Amplicon-based, Agilent HaloplexHS enrichment, Illumina (MiSeq™)
No
≤ 21 days
Not specified
University of Pittsburgh Medical Center Molecular & Genomic Pathology Laboratory Pittsburgh, PA
OncoSeq
28 genes (mutation hotspots)
Amplicon-based, Ion AmpliSeq™ technology
No
7 days
Not specified
Personalized Cancer Mutation Panel
50 genes (targeted regions)
Amplicon-based, Ion AmpliSeq™ technology
Yes, for LOH and MSI analyses
7–14 days
Not specified
University of Texas MD Anderson Cancer Center Houston, TX, USA
Ion Torrent AmpliSeq™ Cancer Panel
46 genes (mutation hotspots)
Amplicon-based, Ion AmpliSeq™ technology
No
Not specified
Not specified
[32]
University of Texas Southwestern Medical Center, Veripath Laboratory Dallas, TX
Cancer Mutation 50-Gene Panel
50 genes
Amplicon-based, Ion Torrent PGM™
No
< 20 days
81,455, 88,381
University of Washington Medical Center Genetics Laboratory Seattle, WA
UW-OncoPlex™
262 genes (select regions and introns)
Hybrid-capture, Illumina (HiSeq™, MiSeq™)
No
4–6 weeks
81,455 (88,381 if applicable)
Washington University Genomics and Pathology Services St. Louis, MO
Solid Tumor Gene Set
65 genes (all coding region and select introns)
Hybrid-capture, Illumina (HiSeq™)
No
3 weeks
81,455
Metadaten
Titel
Erratum to: Managing the genomic revolution in cancer diagnostics
verfasst von
Doreen Nguyen
Christopher D. Gocke
Publikationsdatum
01.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 2/2017
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2193-0

Weitere Artikel der Ausgabe 2/2017

Virchows Archiv 2/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie